These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33011273)

  • 1. APX-115, a pan-NADPH oxidase inhibitor, protects development of diabetic nephropathy in podocyte specific NOX5 transgenic mice.
    Lee ES; Kim HM; Lee SH; Ha KB; Bae YS; Lee SJ; Moon SH; Lee EY; Lee JH; Chung CH
    Free Radic Biol Med; 2020 Dec; 161():92-101. PubMed ID: 33011273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APX-115, a first-in-class pan-NADPH oxidase (Nox) inhibitor, protects db/db mice from renal injury.
    Cha JJ; Min HS; Kim KT; Kim JE; Ghee JY; Kim HW; Lee JE; Han JY; Lee G; Ha HJ; Bae YS; Lee SR; Moon SH; Lee SC; Kim G; Kang YS; Cha DR
    Lab Invest; 2017 Apr; 97(4):419-431. PubMed ID: 28165467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephropathy and elevated BP in mice with podocyte-specific NADPH oxidase 5 expression.
    Holterman CE; Thibodeau JF; Towaij C; Gutsol A; Montezano AC; Parks RJ; Cooper ME; Touyz RM; Kennedy CR
    J Am Soc Nephrol; 2014 Apr; 25(4):784-97. PubMed ID: 24262797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pan-NADPH Oxidase Inhibitor Ameliorates Kidney Injury in Type 1 Diabetic Rats.
    Dorotea D; Kwon G; Lee JH; Saunders E; Bae YS; Moon SH; Lee SJ; Cha DR; Ha H
    Pharmacology; 2018; 102(3-4):180-189. PubMed ID: 30099457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes.
    Gorin Y; Cavaglieri RC; Khazim K; Lee DY; Bruno F; Thakur S; Fanti P; Szyndralewiez C; Barnes JL; Block K; Abboud HE
    Am J Physiol Renal Physiol; 2015 Jun; 308(11):F1276-87. PubMed ID: 25656366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nox (NADPH Oxidase) 1, Nox4, and Nox5 Promote Vascular Permeability and Neovascularization in Retinopathy.
    Deliyanti D; Alrashdi SF; Touyz RM; Kennedy CR; Jha JC; Cooper ME; Jandeleit-Dahm KA; Wilkinson-Berka JL
    Hypertension; 2020 Apr; 75(4):1091-1101. PubMed ID: 32114846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy.
    Jha JC; Gray SP; Barit D; Okabe J; El-Osta A; Namikoshi T; Thallas-Bonke V; Wingler K; Szyndralewiez C; Heitz F; Touyz RM; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    J Am Soc Nephrol; 2014 Jun; 25(6):1237-54. PubMed ID: 24511132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine 1 receptor activation protects mouse diabetic podocytes injury via regulating the PKA/NOX-5/p38 MAPK axis.
    Shao X; Zhang X; Hu J; Gao T; Chen J; Xu C; Wei C
    Exp Cell Res; 2020 Mar; 388(2):111849. PubMed ID: 31954110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NADPH Oxidase Nox5 Accelerates Renal Injury in Diabetic Nephropathy.
    Jha JC; Banal C; Okabe J; Gray SP; Hettige T; Chow BSM; Thallas-Bonke V; De Vos L; Holterman CE; Coughlan MT; Power DA; Skene A; Ekinci EI; Cooper ME; Touyz RM; Kennedy CR; Jandeleit-Dahm K
    Diabetes; 2017 Oct; 66(10):2691-2703. PubMed ID: 28747378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Podocyte NADPH Oxidase 5 Promotes Renal Inflammation Regulated by the Toll-Like Receptor Pathway.
    Holterman CE; Boisvert NC; Thibodeau JF; Kamto E; Novakovic M; Abd-Elrahman KS; Ferguson SSG; Kennedy CRJ
    Antioxid Redox Signal; 2019 May; 30(15):1817-1830. PubMed ID: 30070142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial or vascular smooth muscle cell-specific expression of human NOX5 exacerbates renal inflammation, fibrosis and albuminuria in the Akita mouse.
    Jha JC; Dai A; Holterman CE; Cooper ME; Touyz RM; Kennedy CR; Jandeleit-Dahm KAM
    Diabetologia; 2019 Sep; 62(9):1712-1726. PubMed ID: 31222503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure, regulation, and physiological functions of NADPH oxidase 5 (NOX5).
    García JG; Ansorena E; Izal I; Zalba G; de Miguel C; Milagro FI
    J Physiol Biochem; 2023 May; 79(2):383-395. PubMed ID: 36905456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mTORC2 Signaling Regulates Nox4-Induced Podocyte Depletion in Diabetes.
    Eid S; Boutary S; Braych K; Sabra R; Massaad C; Hamdy A; Rashid A; Moodad S; Block K; Gorin Y; Abboud HE; Eid AA
    Antioxid Redox Signal; 2016 Nov; 25(13):703-719. PubMed ID: 27393154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
    Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-κB signaling and NADPH oxidase.
    Lee JH; Sarker MK; Choi H; Shin D; Kim D; Jun HS
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1332-1340. PubMed ID: 30763641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent of Renox, NOX5 Promotes Renal Inflammation and Fibrosis in Diabetes by Activating ROS-Sensitive Pathways.
    Jha JC; Dai A; Garzarella J; Charlton A; Urner S; Østergaard JA; Okabe J; Holterman CE; Skene A; Power DA; Ekinci EI; Coughlan MT; Schmidt HHHW; Cooper ME; Touyz RM; Kennedy CR; Jandeleit-Dahm K
    Diabetes; 2022 Jun; 71(6):1282-1298. PubMed ID: 35275988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique role of NADPH oxidase 5 in oxidative stress in human renal proximal tubule cells.
    Yu P; Han W; Villar VA; Yang Y; Lu Q; Lee H; Li F; Quinn MT; Gildea JJ; Felder RA; Jose PA
    Redox Biol; 2014; 2():570-9. PubMed ID: 24688893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NOX5: Molecular biology and pathophysiology.
    Touyz RM; Anagnostopoulou A; Rios F; Montezano AC; Camargo LL
    Exp Physiol; 2019 May; 104(5):605-616. PubMed ID: 30801870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular Biology of Superoxide-Generating NADPH Oxidase 5-Implications in Hypertension and Cardiovascular Disease.
    Touyz RM; Anagnostopoulou A; Camargo LL; Rios FJ; Montezano AC
    Antioxid Redox Signal; 2019 Mar; 30(7):1027-1040. PubMed ID: 30334629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ca
    Zhao GJ; Zhao CL; Ouyang S; Deng KQ; Zhu L; Montezano AC; Zhang C; Hu F; Zhu XY; Tian S; Liu X; Ji YX; Zhang P; Zhang XJ; She ZG; Touyz RM; Li H
    Hypertension; 2020 Sep; 76(3):827-838. PubMed ID: 32683902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.